If you have any question, please feel free to email us. We will touch with you as soon as possible.
Kyprolis is indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two previous treatments, including proteasome inhibitors and immunomodulators. For R&D purposes only.
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Generic name | Carfilzomib for Injection |
Trade name | Kyprolis |
Specification | 60mg/vial |
Main ingredients | Carfilzomib |
Appearance | Kyprolis single use sterile vial containing 60 mg, white to pale carfilzomib lyophilized cake or powder. |
MA Holder | Onyx Pharmaceuticals,Inc. |
Manufacturer | Patheon Manufacturing Services, LLC |
Indications |
Kyprolis is indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two previous treatments, including proteasome inhibitors and immunomodulators. The indications were conditionally approved based on objective response rate results from a one-arm clinical trial. Full approval of this product is subject to the results of a confirmatory clinical trial.
|
For more details,pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: Kyprolis 60mg Carfilzomib For Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Adefovir Dipivoxil Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Reference Listed Drugs, AdapaleneGel, Olanzapine Tablets, Acarbose Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China